Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
The Canadian Journal of Cardiology|April 7, 2015
The new pooled cohort equations risk calculatorDavid Preiss, Søren L Kristensen
Diabetic Medicine : a Journal of the British Diabetic Association|May 15, 2021
The effect of sodium-glucose transport protein 2 inhibitors on mortality and heart failure in randomized trials versus observational studiesJesper Krogh, Carsten Hjorthøj, Søren L Kristensen, et al.
Diabetologia|April 27, 2016
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?Naveed Sattar, James McLaren, Søren L Kristensen, et al.
Diabetes & Metabolic Syndrome|January 14, 2022
Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trialMatthew M Y Lee, Søren L Kristensen, Hertzel C Gerstein, et al.
Circulation. Heart Failure|August 31, 2021
Socioeconomic Disparities in Referral for Invasive Hemodynamic Evaluation for Advanced Heart Failure: A Nationwide Cohort StudyJohan Larsson, Søren L Kristensen, Christian Madelaire, et al.
Diabetes Care|April 8, 2018
Risk of Incident Heart Failure in Patients With Diabetes and Asymptomatic Left Ventricular Systolic DysfunctionRasmus Rørth, Pardeep S Jhund, Ulrik M Mogensen, et al.
Diabetes & Metabolism|June 24, 2024
Association of multiple sclerosis with incident diabetes: A nationwide cohort studyJeppe Ravn Jacobsen, Søren L Kristensen, Emil L Fosbøl, et al.
JACC. Heart Failure|June 29, 2019
Burden and Causes of Hospital Admissions in Heart Failure During the Last Year of LifeChristian Madelaire, Finn Gustafsson, Søren L Kristensen, et al.
International Journal of Cardiology|October 29, 2017
Return to the workforce following coronary artery bypass grafting: A Danish nationwide cohort studyJawad H Butt, Rasmus Rørth, Kristian Kragholm, et al.
European Journal of Heart Failure|May 5, 2018
Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival TrialSøren L Kristensen, Rasmus Rørth, Pardeep S Jhund, et al.
Pageof 6